|
Since establishment in 1960, we have transformed from a company focusing on manufacturing and sales to a marketing-oriented international enterprise focusing on the development of new drugs. In the rapidly changing and fiercely competitive market, we do not confine ourselves to the market in Taiwan. Instead, we are committed to becoming the first new drug developer in Asia with explicitly defined roles in the global pharmaceutical market, making a contribution to special Chinese diseases, and to improving the international position of Chinese people in the global biotechnology industry.
|
News
Acceleration of the development of to-BBB’s brain cancer treatment (20090825)
Leiden, The Netherlands, and Taipei, Taiwan, August 20th 2009 TTY Biopharm, the Taiwanese biotech manufacturer of Lipo-Dox®, will become a co-development partner of to-BBB, the Dutch brain drug delivery company, for the manufacturing of brain-targeted doxorubicin liposomes. These liposomes are essential for the clinical development of to-BBB’s lead product for the treatment of brain cancer. Culture Fundamentally Alters the Brain
It's no secret culture influences your food preferences and taste in music. But now scientists say it impacts the hard-wiring of your brain. New research shows that people from different cultures use their brains differently to solve basic perceptual tasks.
|
